DOXEPIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 6 adverse event reports in the FDA FAERS database where DOXEPIN was used for Psoriasis.
Most Reported Side Effects for DOXEPIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Completed suicide | 823 | 20.5% | 823 | 220 |
| Toxicity to various agents | 787 | 19.6% | 640 | 209 |
| Drug ineffective | 420 | 10.5% | 6 | 79 |
| Drug abuse | 256 | 6.4% | 224 | 21 |
| Insomnia | 254 | 6.3% | 20 | 64 |
| Dizziness | 250 | 6.2% | 9 | 86 |
| Fall | 199 | 5.0% | 11 | 85 |
| Pain | 199 | 5.0% | 22 | 62 |
| Somnolence | 194 | 4.8% | 20 | 50 |
| Anxiety | 181 | 4.5% | 0 | 43 |
| Death | 179 | 4.5% | 178 | 21 |
| Off label use | 173 | 4.3% | 26 | 52 |
| Cardio-respiratory arrest | 169 | 4.2% | 169 | 47 |
| Overdose | 165 | 4.1% | 68 | 83 |
| Fatigue | 158 | 3.9% | 9 | 66 |
Other Indications for DOXEPIN
Product used for unknown indication (2,071)
Insomnia (251)
Depression (187)
Sleep disorder (135)
Anxiety (72)
Major depression (67)
Urticaria chronic (61)
Affective disorder (48)
Pruritus (42)
Suicide attempt (38)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)